Matches in Wikidata for { <http://www.wikidata.org/entity/Q92851850> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- Q92851850 description "article scientifique publié en 2020" @default.
- Q92851850 description "articolo scientifico (pubblicato il 2020)" @default.
- Q92851850 description "artikull shkencor i botuar më 01 janar 2020" @default.
- Q92851850 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92851850 description "im Januar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92851850 description "scientific article published on 01 January 2020" @default.
- Q92851850 description "wetenschappelijk artikel" @default.
- Q92851850 description "наукова стаття, опублікована 1 січня 2020" @default.
- Q92851850 description "научна статия" @default.
- Q92851850 name "Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer" @default.
- Q92851850 name "Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer" @default.
- Q92851850 name "Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer" @default.
- Q92851850 type Item @default.
- Q92851850 label "Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer" @default.
- Q92851850 label "Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer" @default.
- Q92851850 label "Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer" @default.
- Q92851850 prefLabel "Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer" @default.
- Q92851850 prefLabel "Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer" @default.
- Q92851850 prefLabel "Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer" @default.
- Q92851850 P1433 Q92851850-D0EC4DF8-BBC6-4EB6-BD60-D1A4E7390A55 @default.
- Q92851850 P1476 Q92851850-12135F35-24EC-4672-BDB1-0C75EE2E90BA @default.
- Q92851850 P2093 Q92851850-1156FE71-BBF2-40F8-ACE5-7E754E96ADBB @default.
- Q92851850 P2093 Q92851850-2979EBDA-0565-428B-8CC1-3A325BD80FD6 @default.
- Q92851850 P2093 Q92851850-3D427F76-755E-40F1-BD4E-E82A40D90214 @default.
- Q92851850 P2093 Q92851850-5409EBD9-D32B-48EC-9F2D-B10FB30DBD6F @default.
- Q92851850 P2093 Q92851850-5428E2F3-1CC0-4202-9D1E-FCB1D29B525E @default.
- Q92851850 P2093 Q92851850-673A02BE-11FD-449A-954B-8C0B6E2AFF2F @default.
- Q92851850 P2093 Q92851850-6E13BAD3-61FD-40B6-9A2B-A6AFD30DAD5B @default.
- Q92851850 P2093 Q92851850-715FAB46-AD63-480D-B538-07AF43519EAF @default.
- Q92851850 P2093 Q92851850-7BAF97B4-1841-4FF9-903D-F21AF77416C3 @default.
- Q92851850 P2093 Q92851850-ACD36078-4A2F-48CE-9C66-BCC56EB37783 @default.
- Q92851850 P2093 Q92851850-B938FC74-D892-4289-8223-91738917A4B6 @default.
- Q92851850 P2093 Q92851850-D73A82A1-0F4C-420A-A588-C962A2D1B368 @default.
- Q92851850 P2093 Q92851850-E78BA32C-0FD0-4C52-B543-41D3DFDAAF73 @default.
- Q92851850 P2093 Q92851850-E9E865C0-2459-4E94-8FE1-A483F3C95D52 @default.
- Q92851850 P2093 Q92851850-F21FBC4D-C115-46D8-BE51-29311B66C930 @default.
- Q92851850 P2860 Q92851850-0385E106-9128-4AC3-9105-C5A34AB5C43D @default.
- Q92851850 P2860 Q92851850-4F3D0EC1-4099-4E0D-84B8-6C2BB9084984 @default.
- Q92851850 P2860 Q92851850-7BE09168-65F5-49D1-9F06-D99953A14B41 @default.
- Q92851850 P304 Q92851850-616426A4-F119-4ADC-9E05-867CBC7B284A @default.
- Q92851850 P31 Q92851850-640DD703-D0FD-4EEE-BF8F-9CDCFC86A78A @default.
- Q92851850 P356 Q92851850-2ABC8A3F-0D66-47A2-A76C-81C5C064599E @default.
- Q92851850 P433 Q92851850-BA459F80-6023-4B17-B6E6-6FD110F27473 @default.
- Q92851850 P478 Q92851850-5AB5BED2-D752-4F55-822A-94EE2EA2419A @default.
- Q92851850 P50 Q92851850-4FC3B71F-4B91-4E6D-88AA-6B0E6EAE2C0B @default.
- Q92851850 P577 Q92851850-45A61623-8079-43D7-A823-97046786E11D @default.
- Q92851850 P698 Q92851850-E5549FF6-F33C-4F1F-A022-8E5456C442B6 @default.
- Q92851850 P921 Q92851850-23B5F340-6B57-412E-9142-63B11655F20C @default.
- Q92851850 P356 J.CELREP.2019.12.056 @default.
- Q92851850 P698 31968251 @default.
- Q92851850 P1433 Q5058165 @default.
- Q92851850 P1476 "Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer" @default.
- Q92851850 P2093 "Akanksha Verma" @default.
- Q92851850 P2093 "Dingcheng Gao" @default.
- Q92851850 P2093 "Eleni Andreopoulou" @default.
- Q92851850 P2093 "Franco Izzo" @default.
- Q92851850 P2093 "Geoffrey Markowitz" @default.
- Q92851850 P2093 "Giorgio Inghirami" @default.
- Q92851850 P2093 "Hyejin Choi" @default.
- Q92851850 P2093 "Jenny Chang" @default.
- Q92851850 P2093 "Kristy A Brown" @default.
- Q92851850 P2093 "Leandro Cerchietti" @default.
- Q92851850 P2093 "Olivier Elemento" @default.
- Q92851850 P2093 "Seongho Ryu" @default.
- Q92851850 P2093 "Sharrell B Lee" @default.
- Q92851850 P2093 "Shira Yomtoubian" @default.
- Q92851850 P2093 "Vivek Mittal" @default.
- Q92851850 P2860 Q28266682 @default.
- Q92851850 P2860 Q28288215 @default.
- Q92851850 P2860 Q29547479 @default.
- Q92851850 P304 "755-770.e6" @default.
- Q92851850 P31 Q13442814 @default.
- Q92851850 P356 "10.1016/J.CELREP.2019.12.056" @default.
- Q92851850 P433 "3" @default.
- Q92851850 P478 "30" @default.
- Q92851850 P50 Q40149511 @default.
- Q92851850 P577 "2020-01-01T00:00:00Z" @default.
- Q92851850 P698 "31968251" @default.
- Q92851850 P921 Q7843332 @default.